Predicting Cardiovascular Risk in People With Diabetic Retinopathy : Study Using Framingham Risk Score
Article Sidebar
-
Diabetic Retinopathy, Diabetes mellitus, Cardiovascular, Framingham Risk Score
Abstract
Introduction: People with type 2 diabetes have an increase risk of cardiovascular disease (CVD). Framingham risk score is used to determine 10 years the risk of CVD in asymptomatic patients for primary prevention. Up to now, there have been no similar studies regarding the risk of CVD in diabetic retinopathy (DR) patients in Indonesia. Therefore, we would like to investigate the corelation between DR and CVD risk through the population using Framingham risk score.
Methods: This research is a Population-Based Cross-sectional Study. The data was taken from the villages in Malang Regency. Participant with diabetes aged > 40 was recruited. The available data was then processed according to the variables and assessed using Framingham Risk Score. The scores were classified as high, intermediate, and low risk.
Results: From 953 samples there were 155 respondents with Diabetes Mellitus (DM), 23 of them experience DR. There were more female participants than men in DM group without DR (73.9%) and DR group (73.9%). A significant correlation between diabetic retinopathy and CVD risk was found (r=0.407, p=0.001). The risk of CVD in 10 years is low in diabetic patients without retinopathy ( p=0.001), but in patients with diabetic retinopathy, the risk of CVD in 10 years is intermediate-high (p=0.001).
Conclusion: There is corelation between Diabetic Retinopathy and risk for cardiovascular disease in intermediate-high category using Framingham risk score.
Full text article
References
Altomare, F., Kherani, A., Lovshin, J., & Diabetes Canada Clinical Practice Guidelines Expert Committee. (2018). Retinopathy. Canadian journal of diabetes, 42, S210-S216.
Heng, L. Z., Comyn, O., Peto, T., Tadros, C., Ng, E., Sivaprasad, S., & Hykin, P. G. (2013). Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabetic Medicine, 30(6), 640-650.
Singh, R., Ramasamy, K., Abraham, C., Gupta, V., & Gupta, A. (2008). Diabetic retinopathy: an update. Indian journal of ophthalmology, 56(3), 179.
Tyagi M, Narayanan R. Diabetic retinopathy and cardiovascular disease. Ophthalmology. 2011 Dec 1;118(12):2529-30.
Johnstone MT, Veves A, editors. Diabetes and cardiovascular disease. Springer Science & Business Media; 2005 May 25.
Fong, D. S., Aiello, L., Gardner, T. W., King, G. L., Blankenship, G., Cavallerano, J. D., ... & Klein, R. (2004). Retinopathy in diabetes. Diabetes care, 27(suppl 1), s84-s87.
Hammes, H. P., Feng, Y., Pfister, F., & Brownlee, M. (2011). Diabetic retinopathy: targeting vasoregression. Diabetes, 60(1), 9-16.
Abu El-Asrar, A. M., Al-Mezaine, H. S., Ola, M. S., Fong, Mizutani, Hammes, ... & Mizutani. (2009). Pathophysiology and management of diabetic retinopathy. Expert Review of Ophthalmology, 4(6), 627-647.
Spranger, J., & Pfeiffer, A. F. H. (2001). New concepts in pathogenesis and treatment of diabetic retinopathy. Experimental and Clinical Endocrinology & Diabetes, 109(Suppl 2), S438S450.
Stewart, M. W. (2010). Pathophysiology of diabetic retinopathy. In Diabetic Retinopathy (pp. 1-30). Springer, New York, NY.
Ciulla, T. A., Amador, A. G., & Zinman, B. (2003). Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes care, 26(9), 2653-2664.
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, Maia M, Mathenge W, Moreker S, Muqit MM, Resnikoff S. Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018 Oct 1;125(10):1608-22.
Bandello F, Zarbin M, Lattanzio R, Zucchiatti I. Clinical Strategies in the Management of Diabetic Retinopathy. Springer-Verlag Berlin An; 2016.
Goshe JM. Diabetic retinopathy for the comprehensive ophthalmologist.
MICHAEL WS. DIABETIC RETINOPATHY: Current Pharmacologic Treatment and Emerging Strategies. SPRINGER VERLAG, SINGAPOR; 2018.
Cheung N, Wang JJ, Rogers SL, Brancati F, Klein R, Sharrett AR, Wong TY, ARIC (Atherosclerosis Risk In Communities) Study Investigators. Diabetic retinopathy and risk of heart failure. Journal of the American College of Cardiology. 2008 Apr 22;51(16):1573-8.
Damkondwar DR, Raman R, Suganeswari G, Kulothungan V, Sharma T. Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy. Indian journal of ophthalmology. 2012 Jan;60(1):45.
Gimeno-Orna JA, Faure-Nogueras E, CastroAlonso FJ, Boned-Juliani B. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus. The American journal of cardiology. 2009 May 15;103(10):1364-7.
Kawasaki R, Tanaka S, Tanaka S, Abe S, Sone H, Yokote K, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N. Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. Ophthalmology. 2013 Mar 1;120(3):574-82.
Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts allcause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes care. 2011 May 1;34(5):1238-44.
Cheung N, Liew G, Wong TY. Current approaches to retinopathy as a predictor of cardiovascular risk. InExperimental Approaches to Diabetic Retinopathy 2010 (Vol. 20, pp. 203-219). Karger Publishers.
El Demerdash F, Refaie W, Allakany R, Tantawy S, Dawood E. Diabetic retinopathy: A predictor of coronary artery disease. The Egyptian Heart Journal. 2012 Jun 1;64(2):63-8.
Kawasaki R, Cheung N, Islam FA, Klein R, Klein BE, Cotch MF, Sharrett AR, O'Leary D, Wong TY, Multi-Ethnic Study of Atherosclerosis. Is diabetic retinopathy related to subclinical cardiovascular disease?. Ophthalmology. 2011 May 1;118(5):8605.
Pradeepa R, Surendar J, Indulekha K, Chella S, Anjana RM, Mohan V. Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study—3. Diabetes technology & therapeutics. 2015 Feb 1;17(2):112-8.
Pandey N, Sahu V. The Impact Of Severity Of Diabetic Retinopathy In Cardiovascular Disease Risk Assesment Using Framingharm Risk Score-a Pilot Study. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS. 2015 Aug 31;4(70):12179-83.
Gerstein HC, Ambrosius WT, Danis R, Ismail-Beigi F, Cushman W, Calles J, Banerji M, Schubart U, Chew EY, ACCORD Study Group. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes care. 2013 May 1;36(5):1266-71.
Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes care. 2007 Feb 1;30(2):292-9.
Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, Genuth S, Goff DC, Leiter LA, IsmailBeigi F, Ambrosius WT. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 2014 Dec 1;121(12):2443-51.
Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. Retinopathy predicts future cardiovascular events among type 2 diabetic patients: The Valpolicella Heart Diabetes Study. Diabetes care. 2006 May 1;29(5):1178-
Dekker JM, STEHOUWER CD, POLAK BC, FULLER JH, SJOLIE AK, KOFINIS A, ROTTIERS R, PORTA M, CHATURVEDI N. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence. Diabetes Care. 2005 Jun;28(6):1383-9.
Rajala U, Pajunpää H, Koskela P, KeinänenKiukaanniemi S. High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care. 2000 Jul 1;23(7):957-61.
Ozawa GY, Bearse MA Jr, Adams AJ. Male-female differences in diabetic retinopathy? Curr Eye Res. 2015 Feb;40(2):234-46.
Kajiwara A, Miyagawa H, Saruwatari J, Kita A, Sakata M, Kawata Y, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K. Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study. Diabetes research and clinical practice. 2014 Mar 1;103(3):e7-10.
Farhangi MA, Jahangiry L. Gender difference in the association between Framingham Risk Score with cardio-metabolic risk factors and psychological distress in patients with metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 Mar 1;14(2):71-5.
Sasongko MB, Agni AN, Wardhana FS, Kotha SP, Gupta P, Widayanti TW, Supanji, Widyaputri F, Widyaningrum R, Wong TY, Kawasaki R. Rationale and methodology for a community-based study of diabetic retinopathy in an Indonesian population with type 2 diabetes mellitus: the Jogjakarta Eye Diabetic Study in the Community. Ophthalmic epidemiology. 2017 Jan 2;24(1):48-56.
Liu L, Quang ND, Banu R, Kumar H, Tham YC, Cheng CY, Wong TY, Sabanayagam C. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS One. 2020 Mar 5;15(3):e0229665.
Klein, R., and B. E. K. Klein. "Blood pressure control and diabetic retinopathy." (2002): 365-367.
Chang YC, Wu WC. Dyslipidemia and diabetic retinopathy. The review of diabetic studies: RDS. 2013;10(2-3):121.
Chang SA. Smoking and type 2 diabetes mellitus. Diabetes & metabolism journal. 2012 Dec 1;36(6):399-403.
Jee SH, Foong AW, Hur NW, Samet JM. Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes care. 2010 Dec 1;33(12):2567-72.
López MI, Díez A, Velilla S, Rueda A, Alvarez A, Pastor JC. Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic epidemiology. 2002 Jan 1;9(3):205-14.
Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. American journal of hypertension. 2004 Jul 1;7(7_Pt_2):7S12S.
Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D'Agostino RB, Levy D. Framingham risk score and prediction of lifetime risk for coronary heart disease. The American journal of cardiology. 2004 Jul 1;94(1):20-4.
Fadlilah S, Sucipto A, Amestiasih T. Usia, Jenis Kelamin, Perilaku Merokok, dan IMT Berhubungan dengan Resiko Penyakit Kardiovaskuler. Jurnal Keperawatan. 2019 Dec 27;11(4):261-8.
Lee IT, Wang CY, Huang CN, Fu CC, Sheu WH. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects. Journal of diabetes and its complications. 2013 May 1;27(3):243-7.
Zhou Y, Wang C, Shi K, Yin X. Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis. Medicine. 2018 Sep;97(36).
Authors
Copyright (c) 2023 Vicia Belladona Carolina Harahap, Mirza Metita, Nadia Artha Dewi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.